KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $47,458 | +14.4% | 12,200 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $41,480 | -63.9% | 12,200 | -42.3% | 0.00% | -66.7% |
| Q3 2022 | $115,000 | +21.1% | 21,150 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $95,000 | -40.3% | 21,150 | -1.9% | 0.01% | -30.0% |
| Q1 2022 | $159,000 | +14.4% | 21,550 | 0.0% | 0.01% | +11.1% |
| Q4 2021 | $139,000 | +13.0% | 21,550 | +1.9% | 0.01% | +12.5% |
| Q3 2021 | $123,000 | -35.9% | 21,150 | +13.4% | 0.01% | -38.5% |
| Q2 2021 | $192,000 | -3.5% | 18,650 | -1.6% | 0.01% | -13.3% |
| Q1 2021 | $199,000 | -11.9% | 18,950 | +28.5% | 0.02% | -21.1% |
| Q4 2020 | $226,000 | – | 14,750 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |